AAAAAA

   
Results: 1-25 | 26-40 |
Results: 26-40/40
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer
Authors: Kenny, FS Hui, R Musgrove, EA Gee, JMW Blamey, RW Nicholson, RI Sutherland, RL Robertson, JFR
Citation: Fs. Kenny et al., Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer, CLIN CANC R, 5(8), 1999, pp. 2069-2076
The prognosis of small primary breast cancers
Authors: Kollias, J Murphy, CA Elston, CW Ellis, IO Robertson, JFR Blamey, RW
Citation: J. Kollias et al., The prognosis of small primary breast cancers, EUR J CANC, 35(6), 1999, pp. 908-912
Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer
Authors: Robertson, JFR Willsher, PC Winterbottom, L Blamey, RW Thorpe, S
Citation: Jfr. Robertson et al., Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer, EUR J CANC, 35(2), 1999, pp. 214-218
The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers
Authors: Robertson, JFR Jaeger, W Syzmendera, JJ Selby, C Coleman, R Howell, A Winstanley, J Jonssen, PE Bombardieri, E Sainsbury, JRC Gronberg, H Kumpulainen, E Blamey, RW
Citation: Jfr. Robertson et al., The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers, EUR J CANC, 35(1), 1999, pp. 47-53
A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex (R)) with intramuscular formestane in postmenopausal women with advanced breast cancer
Authors: Vorobiof, DA Kleeberg, UR Perez-Carrion, R Dodwell, DJ Robertson, JFR Calvo, L Dowsett, M Clack, G
Citation: Da. Vorobiof et al., A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex (R)) with intramuscular formestane in postmenopausal women with advanced breast cancer, ANN ONCOL, 10(10), 1999, pp. 1219-1225
Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer
Authors: Robertson, JFR Howell, A Buzdar, A von Euler, M Lee, D
Citation: Jfr. Robertson et al., Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer, BREAST CANC, 58(2), 1999, pp. 157-162
Immunohistochemical analysis reveals a tumour suppressor-like role for thetranscription factor AP-2 in invasive breast cancer
Authors: Gee, JMW Robertson, JFR Ellis, IO Nicholson, RI Hurst, HC
Citation: Jmw. Gee et al., Immunohistochemical analysis reveals a tumour suppressor-like role for thetranscription factor AP-2 in invasive breast cancer, J PATHOLOGY, 189(4), 1999, pp. 514-520
p21(WAF1) expression and endocrine response in breast cancer
Authors: McClelland, RA Gee, JMW O'Sullivan, L Barnes, DM Robertson, JFR Ellis, IO Nicholson, RI
Citation: Ra. Mcclelland et al., p21(WAF1) expression and endocrine response in breast cancer, J PATHOLOGY, 188(2), 1999, pp. 126-132
An immunohistochemical examination of the expression of E-cadherin, alpha-and beta/gamma-catenins, and alpha 2- and beta 1-integrins in invasive breast cancer
Authors: Gonzalez, MA Pinder, SE Wencyk, PM Bell, JA Elston, CW Nicholson, RI Robertson, JFR Blamey, RW Ellis, IO
Citation: Ma. Gonzalez et al., An immunohistochemical examination of the expression of E-cadherin, alpha-and beta/gamma-catenins, and alpha 2- and beta 1-integrins in invasive breast cancer, J PATHOLOGY, 187(5), 1999, pp. 523-529
BRCA1 expression levels predict distant metastasis of sporadic breast cancer (vol 84, pg 258, 1999)
Authors: Seery, LT Knowlden, JM Gee, JMW Robertson, JFR Kenny, FS Ellis, IO Nicholson, RI
Citation: Lt. Seery et al., BRCA1 expression levels predict distant metastasis of sporadic breast cancer (vol 84, pg 258, 1999), INT J CANC, 84(5), 1999, pp. 544-544
BRCA1 expression levels predict distant metastasis of sporadic breast cancers
Authors: Seery, LT Knowlden, JM Gee, JMW Robertson, JFR Kenny, FS Ellis, IO Nicholson, RI
Citation: Lt. Seery et al., BRCA1 expression levels predict distant metastasis of sporadic breast cancers, INT J CANC, 84(3), 1999, pp. 258-262
Endocrine response and resistance in breast cancer: A role for the transcription factor Fos
Authors: Gee, JMW Willsher, PC Kenny, FS Robertson, JFR Pinder, SE Ellis, IO Nicholson, RI
Citation: Jmw. Gee et al., Endocrine response and resistance in breast cancer: A role for the transcription factor Fos, INT J CANC, 84(1), 1999, pp. 54-61
Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7human breast cancer xenografts
Authors: Jacobs, E Watson, SA Michaeli, D Ellis, IO Robertson, JFR
Citation: E. Jacobs et al., Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7human breast cancer xenografts, BR J CANC, 80(3-4), 1999, pp. 352-359
Long-term follow-up of elderly patients randomized to primary tamoxifen orwedge mastectomy as initial therapy for operable breast cancer
Authors: Kenny, FS Robertson, JFR Ellis, IO Elston, CW Blamey, RW
Citation: Fs. Kenny et al., Long-term follow-up of elderly patients randomized to primary tamoxifen orwedge mastectomy as initial therapy for operable breast cancer, BREAST, 7(6), 1998, pp. 335-339
c-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer
Authors: Willsher, PC Pinder, SE Gee, JMW Ellis, IO Chan, SY Nicholson, RI Blamey, RW Robertson, JFR
Citation: Pc. Willsher et al., c-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer, ANTICANC R, 18(5B), 1998, pp. 3695-3698
Risultati: 1-25 | 26-40 |